Diabetes
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
|
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
HHS-NIH11 |
07/10/2020 |
12/16/2020 |
|
|
Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) |
NIH |
12/11/2019 |
01/07/2023 |
|
|
Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) |
NIH |
12/10/2019 |
11/03/2020 |
|
|
Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32) |
NIH |
09/16/2019 |
09/07/2022 |
|
|
Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31) |
NIH |
09/16/2019 |
09/07/2022 |
|
|
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
NIH |
09/09/2019 |
09/07/2022 |
|
|
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
NIH |
09/09/2019 |
09/07/2022 |
|
|
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) |
NIH |
06/06/2019 |
11/12/2021 |
|
|
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) |
NIH |
04/05/2019 |
05/07/2022 |
|
|
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) |
NIH |
03/18/2019 |
05/07/2022 |
|
|
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) |
NIH |
12/17/2018 |
01/07/2022 |
|
|
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) |
NIH |
8/9/2018 |
6/1/2021 |
|
|
New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional) |
NIH |
8/2/2018 |
6/1/2021 |
|
|
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
NIH |
3/5/2018 |
1/7/2021 |
|
|
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) |
NIH |
3/29/2018 |
5/7/2021 |
|
|
Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional) |
NIH |
2/1/2018 |
1/7/2021 |
|
|
Pilot and Feasibility Therapeutic Clinical Trials in Diabetes, and Endocrine and Metabolic Diseases (R21- Clinical Trial Required) |
NIH |
11/21/2017 |
1/7/2021 |
|
|
Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01-Clinical Trial Required) |
NIH |
10/20/2017 |
1/7/2021 |
|
|
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21) |
NIH |
5/12/2017 |
9/7/2020 |
|
|
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01) |
NIH |
5/12/2017 |
9/7/2020 |